A number of market participants raised concerns that Mars could pursue a
strategy to foreclose upstream competitors from the downstream retail channel.
For example, one competitor noted that post-Transaction, Mars would likely give preferential treatment to its own brands in its downstream retail outlets (AniCura and VetFamily), resulting in reduced access to a key distribution channel and directly impacting their sales: "If this were to go ahead, Mars would have a dominant position in the Veterinary channel because they would own both the distribution channel and Food brands. They would most likely sell their own brands as a priority and block other brands including our own from this channel.
This could potentially cut out a distribution channel/ key customer for our brands and reduce our selling potential."130